GENNEX LABORATORIES
Back to Income Statement
|
GENNEX LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹87 Cr | ₹66 Cr | ₹61 Cr | ₹60 Cr | ₹56 Cr |
What is the latest Revenue of GENNEX LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹87 Cr |
| Mar2024 | ₹66 Cr |
| Mar2023 | ₹61 Cr |
| Mar2022 | ₹60 Cr |
| Mar2021 | ₹56 Cr |
How is Revenue of GENNEX LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹87 Cr | 32.18 | |
| Mar2024 | ₹66 Cr | 7.17 | |
| Mar2023 | ₹61 Cr | 2.62 | |
| Mar2022 | ₹60 Cr | 7.25 | |
| Mar2021 | ₹56 Cr | - | |
Compare Revenue of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹286.9 Cr | -3.7% | -9.4% | -11.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,054.0 Cr | 0.9% | 6.2% | -1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,075.0 Cr | 2% | 4.8% | 4.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,904.0 Cr | 3.6% | 6% | 36.9% | Stock Analytics | |
| CIPLA | ₹107,358.0 Cr | -0.1% | -3% | -8.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,813.0 Cr | 1% | 10.8% | 4.7% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -3.7% |
-9.4% |
-11.6% |
| SENSEX | -1.4% |
0.4% |
8.3% |
You may also like the below Video Courses